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New Evidence of the Importance of Zero Coronary Calcium*Philip Greenland, MDC ardiologists interested in the prevention ofcardiovascular disease (CVD) have beenidentifying and treating high values of major
risk factors for decades. High blood cholesterol, high
blood pressure, high blood glucose, or high body
weight are all standard measures of higher risk and
represent targets of therapy in appropriately selected
patients. Whether low levels of certain clinical mea-
surements would confer low risk of or protection
against disease has typically received much less
attention. However, in the past 20 years, important
new information has emerged on lower risks associ-
ated with certain low values of cardiovascular risk
factors and risk markers.
One especially important example in which low
values of risk factors are associated with very low risk
of CVD is the combination of low risk factors and
healthy habits now known as “ideal cardiovascular
health” (1). Based on original observations by Stamler
et al. (2), what was initially termed the low-risk factor
proﬁle has now been shown to be associated with
lower coronary heart disease risk (2), lower risk of
total mortality (2), lower health care costs (3), lower
rates of stroke (4), lower rates of cancer (5), lower
rates of chronic kidney disease (6), lower rates of
incident coronary calcium (7), slower coronary artery
calcium (CAC) progression (7), and lower rates of
disability (8).
Another important example of the “lower is better
phenomenon” has emerged from studies of coronary
artery calcium. When ﬁrst identiﬁed as a strong
correlate of coronary atherosclerosis, high CAC con-
centrations were heralded as a new way to identify*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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Cardiovascular Imaging or the American College of Cardiology.
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contents of this paper to disclose.high-risk asymptomatic individuals (9). However,
with a progressively lower threshold for initiating
statin therapy and lifestyle habit improvement, the
search for higher risk patients has become less criti-
cally needed. In fact, with lower risk thresholds now
recommended based on recent American College of
Cardiology/American Heart Association guidelines
(10), some have suggested that the main concern is
overtreatment of many who are actually not at very
high risk (11). So, the search for reliable methods to
identify low-risk individuals who can be reassured
has become more compelling.
An obvious way to identify very low risk in-
dividuals is by searching for people with “ideal car-
diovascular health,” but this is relatively uncommon.
Recent evidence suggests that the prevalence of
having 6 or 7 of the ideal cardiovascular health met-
rics among U.S. adults is <5% (12). For these rare low-
risk individuals, a healthy lifestyle and favorable risk
factor levels are cause for reassurance. But what
about the very large numbers of individuals with low
to moderate CVD risk? A CVD event will not develop
in many of them in the near term, so is it possible that
they can be reassured and consider avoidance of
statin therapy safely?
Strong evidence now suggests that adults with no
detectable CAC on computed tomography, even in the
presence of CVD risk factors, are at low risk of coro-
nary heart disease (CHD) events. Silverman et al. (13)
reported on the combined prognostic value of CHD
risk factor burden and CAC scores in 6,698 men and
women from the MESA (Multi-Ethnic Study of
Atherosclerosis) who were followed for CHD events
for a mean of 7 years (13). In the total population
sample, those with no observed CHD risk factors
(including high low-density lipoprotein cholesterol,
high blood pressure, smoking, and low high-density
lipoprotein cholesterol) had a very low risk of
observed CHD (2.1 CHD events per 1,000 person-
years). Individuals with a higher risk factor burden
had higher observed rates of CHD during follow-up.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 8 , 2 0 1 5 Greenland
A U G U S T 2 0 1 5 : 9 1 0 – 2 Editorial Comment
911In a linear fashion, the presence of 1, 2, 3, or 4 risk
factors was associated with higher CHD event rates,
reaching 14.6 CHD events per 1,000 person-years in
those with 3 or 4 risk factors. A similar pattern was
seen for CAC scores, in which those with a CAC score
of 0 experienced CHD events at the rate of 1.8 events
per 1,000 person-years, increasing linearly to 26.3
events per 1,000 person-years in the 12% of MESA
participants with a CAC score >300.
A CAC score of 0 was also highly predictive of lower
risk, even in the presence of CHD risk factors. In the
0-0 group (CAC score of 0 and no risk factors), the rate
of hard CHD events was 0.6 per 1,000 person-years.
Although CHD event rates increased in those with
risk factors, in the presence of a CAC score of 0, rates
of hard CHD in the MESA over 7 years did not exceed
2.1 per 1,000 person-years. Conversely, in those with
0 risk factors, when the CAC score was >300, hard
CHD events occurred at a rate of 8.1 per 1,000 person-
years (13).SEE PAGE 900In this issue of iJACC, Valenti et al. (14) report the
prognosis associated with a CAC score of 0 among a
referred cohort of 9,715 individuals who underwent
CAC imaging at a single center. Patients were fol-
lowed for a mean of 14.6 years. A warranty period was
pre-deﬁned as <1% annual total mortality rate, based
on data from U.S. Social Security Death Index records.
Of 4,864 patients with a CAC score of 0 (mean age,
52.1  10.8 years; 58% male), 229 total deaths
occurred. The death rate during the ﬁrst 13 years of
follow-up in the group with a CAC score of 0 ranged
from 2.5 per 1,000 to 4.2 per 1,000 per year. The
authors deﬁned a low mortality rate as <1% per year
(10/1,000), so by the authors’ deﬁnition, a CAC
score of 0 was associated with at least a 13-year
“warranty” period.
There are both strengths and weaknesses to this
report. On the positive side, assuming the source ofthe death data is complete, total mortality is the most
secure endpoint in studies of this type. Missing here
is any information on nonfatal CVD, and it can easily
be argued that a given patient would like to know
more than his or her risk of death. A nonfatal
myocardial infarction cannot be considered benign,
nor can angina leading to disability or revasculariza-
tion. Most patients are likely to want to know the
“warranty” period for all cardiovascular events, not
just fatal events. Nonetheless, it is reassuring to see
that the rate of death remained low in these asymp-
tomatic middle-aged individuals for up to 13 years.
This observation adds to the extensive data now
available on the prognostic implications of a CAC
score of 0.
There are several take-home messages from this
report, put in the context of other low-risk prognostic
features. Risk factors, when fully absent, represent a
very convincing low-risk phenotype. One major goal
of the American Heart Association’s “Life’s Simple
Seven” program is to increase the proportion of adults
who achieve and maintain ideal cardiovascular health
(1). In the clinical setting, an important test of low-
risk status is a CAC score of 0. Here is truly a situa-
tion in which nothing is really “something.”When the
question arises as to whether a given patient may be
at low enough CVD—or total mortality—risk to justify
avoidance of prolonged use of statin medications,
CAC testing appears to be a useful and evidence-
based approach. If the CAC score is 0, one can as-
sume a very low rate of total mortality for up to
13 years, as well as a very low rate of hard CHD
events for up to $7 years based on MESA data.
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